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Tramsesophageal atria1 stimulation ITAS) was performed af 
ter all conventional antiarrhythm~c dru 
ped for at least 5 half-lives before testing,using a mode 
rotocol: single and 
li during sinus rhythm and during 600 and 400 msec cycle 
eft atria1 dimension,duration of PAF,eleetrophysiolo&ic 
of 12+_4 months,2 responders (14%) and 5 non responders(63 
%) had recurrences of PAF (P 0.005). 
We conclude that oral F is effective and safe for treat 
ing pts with PAF. TAS is a rapid,simple and ngt expensive 
method in predicting the response to oral F. 
~~eca~~ide (Flee) may increase energy requirements 
for ventricular fibrillation cardioversion. Since Flee 
is used for atria1 fib 
whether Flee ter 
cardioverting (apex-scapula 
patches) 39 pa ;Its sing successive 
shocks of SO joules (J and 360 3. The 
distribution, by 3, for ~ardioversion for Flee versus 
5% 2005 3603 
Flee (n=14) O/l 9/?4 
*non-Flee (nm23) 4/2 2/23 
65510) left atria1 sit 
Three pts crossed from 
energy level increase. 
seen in 3/14 Flee pts and O/23 non-Flee: ~t~~(~~=.OS, chi 
sq)= These data suggest that Flee increases energies 
fooc,"F cardioversion and may produce pauses after the 
. 
